Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study.

Chuanxi ZhengJianguo FangYitian WangYong ZhouChongqi TuChongqi Tu

Published in: Journal of cancer research and clinical oncology (2021)

Apatinib is an effective and well-tolerated option for patients with advanced extremity DF. Indeed, further prospective, randomized studies with larger cases are required to fully explore the clinical utility of apatinib in DF.

Keyphrases

soft tissue
double blind
open label
placebo controlled
phase iii
randomized controlled trial
phase ii
case control